Elvira Rostanzo1, Marco Marchetti2, Ilenia Casini1, Anna Maria Aloisi1. 1. Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy. 2. PhD School of Applied Medical-Surgical Sciences, University of Rome "Tor Vergata", 00133 Rome, Italy.
Abstract
BACKGROUND: many patients who struggle to lose weight are unable to cut down certain ultra-processed, refined types of food with a high glycemic index. This condition is linked to responses similar to addiction that lead to overeating. A very-low-calorie ketogenic diet (VLCKD) with adequate protein intake could be considered a valid dietary approach. The aim of the present study was to evaluate the feasibility of a VLCKD in women with binge eating and/or food addiction symptoms. METHODS: subjects diagnosed with binge eating and/or food addiction symptoms (measured with the Binge Eating Scale and the Yale Food Addiction Scale 2.0) were asked to follow a VLCKD with protein replacement for 5-7 weeks (T1) and a low-calorie diet for 11-21 weeks (T2). Self-reported food addiction and binge eating symptoms and body composition were tested at T0 (baseline) and at the end of each diet (T1 and T2 respectively); Results: five women were included in the study. Mean age was 36.4 years (SEM = 4.95) and mean BMI was 31.16 (SEM = 0.91). At T0, two cases of severe food addiction, one case of mild food addiction, one case of binge eating with severe food addiction, and one case of binge eating were recorded. Weight loss was recorded at both T1 and T2 (ranging from 4.8% to 11.6% of the initial body weight at T1 and from 7.3% to 12.8% at T2). No case of food addiction and/or binge eating symptoms was recorded at T2. Muscle mass was preserved. CONCLUSIONS: recent findings have highlighted the potential therapeutic role of ketogenic diets for the treatment of addiction to high-calorie, ultra-processed and high-glycemic food. Our pilot study demonstrates the feasibility of a ketogenic diet in women with addictive-like eating disorders seeking to lose weight.
BACKGROUND: many patients who struggle to lose weight are unable to cut down certain ultra-processed, refined types of food with a high glycemic index. This condition is linked to responses similar to addiction that lead to overeating. A very-low-calorie ketogenic diet (VLCKD) with adequate protein intake could be considered a valid dietary approach. The aim of the present study was to evaluate the feasibility of a VLCKD in women with binge eating and/or food addiction symptoms. METHODS: subjects diagnosed with binge eating and/or food addiction symptoms (measured with the Binge Eating Scale and the Yale Food Addiction Scale 2.0) were asked to follow a VLCKD with protein replacement for 5-7 weeks (T1) and a low-calorie diet for 11-21 weeks (T2). Self-reported food addiction and binge eating symptoms and body composition were tested at T0 (baseline) and at the end of each diet (T1 and T2 respectively); Results: five women were included in the study. Mean age was 36.4 years (SEM = 4.95) and mean BMI was 31.16 (SEM = 0.91). At T0, two cases of severe food addiction, one case of mild food addiction, one case of binge eating with severe food addiction, and one case of binge eating were recorded. Weight loss was recorded at both T1 and T2 (ranging from 4.8% to 11.6% of the initial body weight at T1 and from 7.3% to 12.8% at T2). No case of food addiction and/or binge eating symptoms was recorded at T2. Muscle mass was preserved. CONCLUSIONS: recent findings have highlighted the potential therapeutic role of ketogenic diets for the treatment of addiction to high-calorie, ultra-processed and high-glycemic food. Our pilot study demonstrates the feasibility of a ketogenic diet in women with addictive-like eating disorders seeking to lose weight.
Authors: Susan A Masino; Tianfu Li; Panos Theofilas; Ursula S Sandau; David N Ruskin; Bertil B Fredholm; Jonathan D Geiger; Eleonora Aronica; Detlev Boison Journal: J Clin Invest Date: 2011-06-23 Impact factor: 14.808
Authors: G Merra; R Miranda; S Barrucco; P Gualtieri; M Mazza; E Moriconi; M Marchetti; T F M Chang; A De Lorenzo; L Di Renzo Journal: Eur Rev Med Pharmacol Sci Date: 2016-07 Impact factor: 3.507
Authors: P Sumithran; L A Prendergast; E Delbridge; K Purcell; A Shulkes; A Kriketos; J Proietto Journal: Eur J Clin Nutr Date: 2013-05-01 Impact factor: 4.016
Authors: Matthew Carmen; Debra Lynn Safer; Laura R Saslow; Tro Kalayjian; Ashley E Mason; Eric C Westman; Shebani Sethi Dalai Journal: J Eat Disord Date: 2020-01-29